頭頸部扁平上皮癌培養細胞に対するEpidermal Growth Factorの影響
頭頸部扁平上皮癌培養細胞に対する上皮成長因子 (Epidermal Growth Factor;EGF) の作用, またこれらの細胞のEGFリセプター (EGFR) 発現, 抗EGFR抗体の作用, 化学療法の感受性に対する影響などを検討した。培養上清のEGF産生量はすべて検出限界値以下であった。EGFRは全ての細胞に発現し, 過剰発現する細胞もみられた。サイトカイン (IFNα, β, TNFα) によってEGFR発現は増強し, EGFとの併用で増殖能も上昇した。EGFによって増殖促進される細胞にはセルサイクルの変化すなわちS+G2M期への集積がみられ, この増殖促進効果は抗EGFR抗体添加に...
Saved in:
Published in | 耳鼻咽喉科展望 Vol. 40; no. 2; pp. 156 - 164 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
耳鼻咽喉科展望会
15.04.1997
|
Online Access | Get full text |
ISSN | 0386-9687 1883-6429 |
DOI | 10.11453/orltokyo1958.40.156 |
Cover
Abstract | 頭頸部扁平上皮癌培養細胞に対する上皮成長因子 (Epidermal Growth Factor;EGF) の作用, またこれらの細胞のEGFリセプター (EGFR) 発現, 抗EGFR抗体の作用, 化学療法の感受性に対する影響などを検討した。培養上清のEGF産生量はすべて検出限界値以下であった。EGFRは全ての細胞に発現し, 過剰発現する細胞もみられた。サイトカイン (IFNα, β, TNFα) によってEGFR発現は増強し, EGFとの併用で増殖能も上昇した。EGFによって増殖促進される細胞にはセルサイクルの変化すなわちS+G2M期への集積がみられ, この増殖促進効果は抗EGFR抗体添加により抑制された。EGF添加によりcisplatinの腫瘍に対するinhibition rateは高まり, 抗腫瘍効果においてcisplatinと抗EGFR抗体の相乗効果がみられた。 |
---|---|
AbstractList | 頭頸部扁平上皮癌培養細胞に対する上皮成長因子 (Epidermal Growth Factor;EGF) の作用, またこれらの細胞のEGFリセプター (EGFR) 発現, 抗EGFR抗体の作用, 化学療法の感受性に対する影響などを検討した。培養上清のEGF産生量はすべて検出限界値以下であった。EGFRは全ての細胞に発現し, 過剰発現する細胞もみられた。サイトカイン (IFNα, β, TNFα) によってEGFR発現は増強し, EGFとの併用で増殖能も上昇した。EGFによって増殖促進される細胞にはセルサイクルの変化すなわちS+G2M期への集積がみられ, この増殖促進効果は抗EGFR抗体添加により抑制された。EGF添加によりcisplatinの腫瘍に対するinhibition rateは高まり, 抗腫瘍効果においてcisplatinと抗EGFR抗体の相乗効果がみられた。 |
Author | 加賀, 潤 周, 莉新 三上, 康和 佃, 守 新井, 泰弘 湯山, 誠一郎 持松, いづみ 松田, 秀樹 |
Author_xml | – sequence: 1 fullname: 周, 莉新 organization: 横浜市立大学医学部耳鼻咽喉科学教室 – sequence: 1 fullname: 新井, 泰弘 organization: 横浜市立大学医学部耳鼻咽喉科学教室 – sequence: 1 fullname: 三上, 康和 organization: 横浜市立大学医学部耳鼻咽喉科学教室 – sequence: 1 fullname: 持松, いづみ organization: 横浜市立大学医学部耳鼻咽喉科学教室 – sequence: 1 fullname: 松田, 秀樹 organization: 横浜市立大学医学部耳鼻咽喉科学教室 – sequence: 1 fullname: 加賀, 潤 organization: 横浜市立大学医学部耳鼻咽喉科学教室 – sequence: 1 fullname: 佃, 守 organization: 横浜市立大学医学部耳鼻咽喉科学教室 – sequence: 1 fullname: 湯山, 誠一郎 organization: 横浜市立大学医学部耳鼻咽喉科学教室 |
BookMark | eNpNUL1OwkAAvhhMROQNHHyBYq_XXu9GQ_gxIdGBvblrr1IslFybGMbKJPoCOAiDg4kRNTrAoD5Mrdi3sAnGuHx_-fIN3zYo9IO-AGAXqhUIdQPtB9KPgtNhAKlBKnqeGngDFCEhSMG6RgugqCKCFYqJuQXKYehxVTWISTE2i-A4mz1ks0U2uvu6iNPly-divLqeryZX6XSZ3Y5Xr0_fo5skvk8f35N4kpxf1gaeI2SP-XsNGZxFnb06s6NAJvE8fXvOph87YNNlfijKv1wC7XqtXW0qraPGYfWgpXQJZYpwEbeZCRHVuEG5TbimmtgxTEq4QwxTOI6OciFcjHVoq67OOEUcOgTmVnNQCTTXs90wYifCGkivx-TQYjLybF9Y_0-xdNXS1pB_81exO0xaXYZ-AHGzeHo |
ContentType | Journal Article |
Copyright | 耳鼻咽喉科展望会 |
Copyright_xml | – notice: 耳鼻咽喉科展望会 |
DOI | 10.11453/orltokyo1958.40.156 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1883-6429 |
EndPage | 164 |
ExternalDocumentID | article_orltokyo1958_40_2_40_2_156_article_char_ja |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF RJT |
ID | FETCH-LOGICAL-j89a-ef3bca71392b59bc8b2076d5798bd857edd43d85ef6641c0f4ab93b1d8141c2d3 |
ISSN | 0386-9687 |
IngestDate | Wed Sep 03 06:29:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 2 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j89a-ef3bca71392b59bc8b2076d5798bd857edd43d85ef6641c0f4ab93b1d8141c2d3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/orltokyo1958/40/2/40_2_156/_article/-char/ja |
PageCount | 9 |
ParticipantIDs | jstage_primary_article_orltokyo1958_40_2_40_2_156_article_char_ja |
PublicationCentury | 1900 |
PublicationDate | 1997/04/15 |
PublicationDateYYYYMMDD | 1997-04-15 |
PublicationDate_xml | – month: 04 year: 1997 text: 1997/04/15 day: 15 |
PublicationDecade | 1990 |
PublicationTitle | 耳鼻咽喉科展望 |
PublicationTitleAlternate | 耳展 |
PublicationYear | 1997 |
Publisher | 耳鼻咽喉科展望会 |
Publisher_xml | – name: 耳鼻咽喉科展望会 |
References | 15) Ozawa S, Ueda M, Ando N, et al : High incidence of EGF receptor hyperproduction in esophageal squamous cell carcinomas. Int J Cancer 39 : 333-337, 1987. 21) Maurizi M, Scambia G, Beneditti PP, et al : EGF receptor expression in primary laryngeal cancer : correlation with clinicopathological feature and prognostic significance. Int J Cancer 52 : 862-866, 1992. 13) Sporn M, Roberts A : Autocrine growth factors and cancer. Nature 313 : 745-747, 1985. 10) Shoyab M, Plowman GD, McDonald VL, et al : Structure and function of human amphiregulin : a member of the epidermal growth factor family. Science 243 : 1074-1076, 1989. 35) Jose B, Larry N, Hideo M, et al : Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85 : 1327-1333, 1993. 32) Haas I, Koldovsky P, Bier H : Immunohistochemical studies of advanced laryngeal and hypopharyngeal carcinomas 3 days after administration of monoclonal antibody against epidermal growth factor receptor. Laryngorhinootologie 73 : 626-630, 1994. 26) Osaku M, Ueda M, Ando N, et al : Targeted killing of squamous carcinoma cells by a monoclonal antibody-pepleomycin conjugate which recognizes the EGF receptor. Anticancer Res 11 : 1951-1956, 1991. 36) 小澤壮治, 池田佳史, 篠崎浩治, 他 : 遺伝子異常からみた食道癌の臨床特性. 日気食会報46 : 115-120, 1995. 19) Dassonville O, Formento JL, Francoual M, et al : Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11 : 1873-1878, 1993. 33) Modjtahedi H, Hickish T, Nicolson M, et al : Phase I trial and tumor localization of the anti-EGFR monoclonal antibody ICR 62 in head and neck or lung cancer. Br J Cancer 73 : 228-235, 1996. 23) 新井泰弘, 佃守, 久保田彰, 他 : 頭頸部扁平上皮癌の新鮮凍結組織を用いたDNA ploidyの解析.日耳鼻97 : 254-259, 1994. 34) Perez-Soler R, Donato NJ, Shin DM, et al Tumor epidermal growth factor receptor studies in patients with non-small cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852. J Clin Oncol 12 : 730-739, 1994. 5) 佃, 守 : 頭頸部癌における染色体, 遺伝子異常研究の現況.耳喉頭頸68 : 751-766, 1996 17) Stanton P, Richards S, Reeves J, et al : Epidermal growth factor expreesion by human squamous cell carcinomas of the head and neck, cell lines and xenografts. Br J Cancer 70 : 427-433, 1994. 22) Irish JC, Bernstein A : Oncogenes in head and neck cancer. Laryngoscope 103 : 42-52, 1993. 2) Gregory H : In vivo aspects of urogastroneepidermal growth factor. J Cell Sci Suppl 3 : 11-17, 1985. 3) Carpenter G : aeapidermal growth factor, its receptor, and related proteins. Exp Cell Res 164 : 1-10, 1986. 9) Ullrich A, Coussens L, Hayflik J, et al : Human epidermal growth factor receptor cDNA sequence and abberant expression of the amplified gene in A 431 epidermoid carcinoma cells. Nature 309 : 418-425, 1984. 11) Higashiyama S, Lau K, Besner GE, et al : Structure of heparin-binding EGF-like growth factor : multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 267 : 6205-6212, 1992. 14) Ozawa S, Ueda M, Ando N, et al : Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach. Jpn J Cancer Res 79 : 1201-1207, 1988. 12) Kimura H, Fischer WH, Schubert D : Structure, expression and function of a schwannoma-derived growth factor. Nature 348 : 257-260, 1990. 6) 三上康和 : 頭頸部扁平上皮癌細胞のBasic Fibroblast Growth Factor産生と血管新生.耳展36 : 685-695, 1993. 4) Carpenter G : Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56 : 881-914, 1987. 8) 蒲生忍, 清水信義 : 増殖因子レセプター.ホルモンと臨床42 : 71-80, 1995. 30) Kroning R, Jones JA, Hom DK, et al : Enhancement of drug sensitivity of human malignancies by epidermal growth factor. Br J Cancer 72 : 615-619, 1995. 16) Ozanne B, Schum A, Richards CS, et al : Evidence for increased EGF receptor in epidermal malignancies. Cancer Cells 3 : 41-49, 1985. 31) Bonner JA, Maihle NJ, Folven BR : The inteaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities. Int J Radiat Oncol Biol Phys 29 : 243-247, 1994. 1) Cohen S : Isoration of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 237 : 1555-4562, 1962. 25) Modjtahedi H, Eccles S, Scandle J : Differentiation or immune destruction : two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Canser Res 54 : 1695-1701, 1994. 18) Ohi K, Suzuki M, Koike S, et al : Expression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck. J Otolaryngol Jpn 96 : 2039-2043, 1993. 20) Starkey RH, Orth DN : Radioimmunoassay of human epidermal growth factor (urogastrone). J Clin Endocr Metab 45 : 1144-1153, 1987. 24) 清河信敬, 藤本純一郎, Mien-Chie H : 受容体型チロシンキナーゼEGFRの細胞周期依存性機能調節機構日本癌学会総会記事55 : 90, 1996. 28) Giovanni S, Pierluigi BP, Gabriella F : Effect of recombinant human interferon-alpha/2 b on epidermal-growth-factor-, estrogen-and progesterone-receptor exprression in primary cervical cancer. Int J Cancer 58 : 769-773, 1994. 27) Michele C, Annalisa L, Stefania C : α-interferon potentiates epidermal growth factor receptor mediated effects on human epidermoid carcinoma KB cells. Int J Cancer 61 : 342-347, 1995. 7) 蒲生 忍, 清水信義 : 上皮増殖因子とそのレセプター.日本臨床50 : 193-200, 1992. 29) Mochimatsu M, Tsukuda M, Furukawa S, et al : The sensitivity of head and neck squamous cell carcinomas to tumor necrosis factor-α. Biotherapy 6 : 239-244, 1994. |
References_xml | – reference: 14) Ozawa S, Ueda M, Ando N, et al : Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach. Jpn J Cancer Res 79 : 1201-1207, 1988. – reference: 24) 清河信敬, 藤本純一郎, Mien-Chie H : 受容体型チロシンキナーゼEGFRの細胞周期依存性機能調節機構日本癌学会総会記事55 : 90, 1996. – reference: 36) 小澤壮治, 池田佳史, 篠崎浩治, 他 : 遺伝子異常からみた食道癌の臨床特性. 日気食会報46 : 115-120, 1995. – reference: 21) Maurizi M, Scambia G, Beneditti PP, et al : EGF receptor expression in primary laryngeal cancer : correlation with clinicopathological feature and prognostic significance. Int J Cancer 52 : 862-866, 1992. – reference: 15) Ozawa S, Ueda M, Ando N, et al : High incidence of EGF receptor hyperproduction in esophageal squamous cell carcinomas. Int J Cancer 39 : 333-337, 1987. – reference: 33) Modjtahedi H, Hickish T, Nicolson M, et al : Phase I trial and tumor localization of the anti-EGFR monoclonal antibody ICR 62 in head and neck or lung cancer. Br J Cancer 73 : 228-235, 1996. – reference: 13) Sporn M, Roberts A : Autocrine growth factors and cancer. Nature 313 : 745-747, 1985. – reference: 26) Osaku M, Ueda M, Ando N, et al : Targeted killing of squamous carcinoma cells by a monoclonal antibody-pepleomycin conjugate which recognizes the EGF receptor. Anticancer Res 11 : 1951-1956, 1991. – reference: 28) Giovanni S, Pierluigi BP, Gabriella F : Effect of recombinant human interferon-alpha/2 b on epidermal-growth-factor-, estrogen-and progesterone-receptor exprression in primary cervical cancer. Int J Cancer 58 : 769-773, 1994. – reference: 12) Kimura H, Fischer WH, Schubert D : Structure, expression and function of a schwannoma-derived growth factor. Nature 348 : 257-260, 1990. – reference: 32) Haas I, Koldovsky P, Bier H : Immunohistochemical studies of advanced laryngeal and hypopharyngeal carcinomas 3 days after administration of monoclonal antibody against epidermal growth factor receptor. Laryngorhinootologie 73 : 626-630, 1994. – reference: 3) Carpenter G : aeapidermal growth factor, its receptor, and related proteins. Exp Cell Res 164 : 1-10, 1986. – reference: 27) Michele C, Annalisa L, Stefania C : α-interferon potentiates epidermal growth factor receptor mediated effects on human epidermoid carcinoma KB cells. Int J Cancer 61 : 342-347, 1995. – reference: 6) 三上康和 : 頭頸部扁平上皮癌細胞のBasic Fibroblast Growth Factor産生と血管新生.耳展36 : 685-695, 1993. – reference: 30) Kroning R, Jones JA, Hom DK, et al : Enhancement of drug sensitivity of human malignancies by epidermal growth factor. Br J Cancer 72 : 615-619, 1995. – reference: 5) 佃, 守 : 頭頸部癌における染色体, 遺伝子異常研究の現況.耳喉頭頸68 : 751-766, 1996 – reference: 11) Higashiyama S, Lau K, Besner GE, et al : Structure of heparin-binding EGF-like growth factor : multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 267 : 6205-6212, 1992. – reference: 23) 新井泰弘, 佃守, 久保田彰, 他 : 頭頸部扁平上皮癌の新鮮凍結組織を用いたDNA ploidyの解析.日耳鼻97 : 254-259, 1994. – reference: 2) Gregory H : In vivo aspects of urogastroneepidermal growth factor. J Cell Sci Suppl 3 : 11-17, 1985. – reference: 9) Ullrich A, Coussens L, Hayflik J, et al : Human epidermal growth factor receptor cDNA sequence and abberant expression of the amplified gene in A 431 epidermoid carcinoma cells. Nature 309 : 418-425, 1984. – reference: 8) 蒲生忍, 清水信義 : 増殖因子レセプター.ホルモンと臨床42 : 71-80, 1995. – reference: 25) Modjtahedi H, Eccles S, Scandle J : Differentiation or immune destruction : two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Canser Res 54 : 1695-1701, 1994. – reference: 19) Dassonville O, Formento JL, Francoual M, et al : Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11 : 1873-1878, 1993. – reference: 34) Perez-Soler R, Donato NJ, Shin DM, et al Tumor epidermal growth factor receptor studies in patients with non-small cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852. J Clin Oncol 12 : 730-739, 1994. – reference: 17) Stanton P, Richards S, Reeves J, et al : Epidermal growth factor expreesion by human squamous cell carcinomas of the head and neck, cell lines and xenografts. Br J Cancer 70 : 427-433, 1994. – reference: 20) Starkey RH, Orth DN : Radioimmunoassay of human epidermal growth factor (urogastrone). J Clin Endocr Metab 45 : 1144-1153, 1987. – reference: 31) Bonner JA, Maihle NJ, Folven BR : The inteaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities. Int J Radiat Oncol Biol Phys 29 : 243-247, 1994. – reference: 1) Cohen S : Isoration of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 237 : 1555-4562, 1962. – reference: 18) Ohi K, Suzuki M, Koike S, et al : Expression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck. J Otolaryngol Jpn 96 : 2039-2043, 1993. – reference: 22) Irish JC, Bernstein A : Oncogenes in head and neck cancer. Laryngoscope 103 : 42-52, 1993. – reference: 35) Jose B, Larry N, Hideo M, et al : Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85 : 1327-1333, 1993. – reference: 7) 蒲生 忍, 清水信義 : 上皮増殖因子とそのレセプター.日本臨床50 : 193-200, 1992. – reference: 16) Ozanne B, Schum A, Richards CS, et al : Evidence for increased EGF receptor in epidermal malignancies. Cancer Cells 3 : 41-49, 1985. – reference: 29) Mochimatsu M, Tsukuda M, Furukawa S, et al : The sensitivity of head and neck squamous cell carcinomas to tumor necrosis factor-α. Biotherapy 6 : 239-244, 1994. – reference: 4) Carpenter G : Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56 : 881-914, 1987. – reference: 10) Shoyab M, Plowman GD, McDonald VL, et al : Structure and function of human amphiregulin : a member of the epidermal growth factor family. Science 243 : 1074-1076, 1989. |
SSID | ssib005879667 ssib005902162 ssib005879668 ssib058493089 ssib029852170 ssj0066717 ssib007484760 ssib002004161 |
Score | 1.4508786 |
Snippet | 頭頸部扁平上皮癌培養細胞に対する上皮成長因子 (Epidermal Growth Factor;EGF) の作用, またこれらの細胞のEGFリセプター (EGFR) 発現, 抗EGFR抗体の作用,... |
SourceID | jstage |
SourceType | Publisher |
StartPage | 156 |
Title | 頭頸部扁平上皮癌培養細胞に対するEpidermal Growth Factorの影響 |
URI | https://www.jstage.jst.go.jp/article/orltokyo1958/40/2/40_2_156/_article/-char/ja |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 耳鼻咽喉科展望, 1997/04/15, Vol.40(2), pp.156-164 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEI5KuXBBIED8aw_4hFLyY8f20dlNVYFAIBWptyi_QkvVraqtENyWnii8QDnQHjggIQoIDu0BeAdeYVnKvgUzdnY3lB4ocIkm1ufxeCa2Z5J4bFlXHClkWUCYmmZJYMOEh6cBetzOqchyHuRpWuLe4Zu3grm79PoCW5g68rX219JqN53JHh24r-RvrAplYFfcJXsIy46ZQgHQYF-4goXh-kc2JpEkyiGqVRGhQEL4RAEREAG0SyJGQklCn0QUAUKRiBOpiIo0AZgmYuQswpAPrTAh4B0SCWQoAewjNxUiWAF4VAIckPCICCM8bhZm-kV8pfWge-_qrD7NZ1Q10rK0SOhiO9jgLz8V6qYcLSnI2yShbkp6WAUJ3SGQS4HUplvQOMOOyiaR409HGuuiCuDp0TwjXTFADqEzgVUFWi8KOWl8gAJgKUMZpJjgjfrkRI8az7ByyCtRRbPOHzSLBoCGWqgvjdeqEHSkE1YRlSryakMix09JZgeqHjH_qBstMxCqNu_7IrBlUPkhhVmXhPBtCBVlfeEyea6qAerVViGXBTWHxjVp4n9fK6k-8aSzstjt3H_YwaxDMxRfNe5LTa6dneoZj-vomDqxZy5QKR5BcLtg3IaY5ajHuf514sadWkiLGd5qe6mZ4BBx8333tRRzErzQWkpLzH3LJyG9JwU4oJM1B_xp6Tt4goLxxoC1PnV7rNRq-yx2_toBXQdHtA1h2eiXTu1lzp-wjlfhYUOZTp60ptrJKev2cOvNcGtnuPbq-5PeYPfDt531vefbexvPBpu7w5frex_f_Vh70e-9Hrz93O9t9B8_HY_DhhmHDTMO-73twaf3w80vp6352Wi-OWdXJ6HYbSETuyh9mEo5BGteymSaidRzYB5lXIo0F4wXeU59IIoyCKibOSVNUumnbi5cuPVy_4w1vdRZKs5aDZYyj6Ulhzgoo57wkjIRmUgSh2ZunlDnnKVM_-Nlk-0mPrzlz_8HHhesY5PBdtGa7q6sFpfA_e-ml_Xz9BMY6taj |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%A0%AD%E9%A0%B8%E9%83%A8%E6%89%81%E5%B9%B3%E4%B8%8A%E7%9A%AE%E7%99%8C%E5%9F%B9%E9%A4%8A%E7%B4%B0%E8%83%9E%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8BEpidermal+Growth+Factor%E3%81%AE%E5%BD%B1%E9%9F%BF&rft.jtitle=%E8%80%B3%E9%BC%BB%E5%92%BD%E5%96%89%E7%A7%91%E5%B1%95%E6%9C%9B&rft.au=%E5%91%A8%2C+%E8%8E%89%E6%96%B0&rft.au=%E6%96%B0%E4%BA%95%2C+%E6%B3%B0%E5%BC%98&rft.au=%E4%B8%89%E4%B8%8A%2C+%E5%BA%B7%E5%92%8C&rft.au=%E6%8C%81%E6%9D%BE%2C+%E3%81%84%E3%81%A5%E3%81%BF&rft.date=1997-04-15&rft.pub=%E8%80%B3%E9%BC%BB%E5%92%BD%E5%96%89%E7%A7%91%E5%B1%95%E6%9C%9B%E4%BC%9A&rft.issn=0386-9687&rft.eissn=1883-6429&rft.volume=40&rft.issue=2&rft.spage=156&rft.epage=164&rft_id=info:doi/10.11453%2Forltokyo1958.40.156&rft.externalDocID=article_orltokyo1958_40_2_40_2_156_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-9687&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-9687&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-9687&client=summon |